 use molecular method distribut epitop topoisomeras sera scleroderma patient initi molecular character autoimmun respons dna topoisomeras topo sera patient scleroderma healthi control subject subclon portion topo twenty-thre sera independ epitop molecul anti-topo non-organ-specif autoantibodi date polyclon multifoc clone protein suitabl sensit earli detect anti-topo clinic set